Huang Chih-Yang, Kuo Chia-Hua, Pai Pei-Ying, Ho Tsung-Jung, Lin Yueh-Min, Chen Ray-Jade, Tsai Fuu-Jen, Vijaya Padma V, Kuo Wei-Wen, Huang Chih-Yang
Translation Research Core, China Medical University Hospital, China Medical University, Taichung, Taiwan.
Department of Sports Sciences, University of Taipei, Taipei, Taiwan.
Data Brief. 2017 Nov 20;16:521-526. doi: 10.1016/j.dib.2017.11.040. eCollection 2018 Feb.
In association with the published article "Inhibition of HSF2 SUMOylation MEL18 upregulates IGF-IIR and leads to hypertension-induced cardiac hypertrophy" (Huang et al., 2017) [1], this data article contains information about deSUMOylation of HSF2 on lysine 82 on angiotensin II (ANG II) -induced cardiac hypertrophy, which is mediated by MEL18. Isolated adult human whole heart tissue showed MEL18-mediated HSF2-IGF-IIR pathway is upregulated in hypertension human heart, compared to health human heart.
与已发表的文章《抑制HSF2的SUMO化通过MEL18上调IGF-IIR并导致高血压诱导的心脏肥大》(Huang等人,2017年)[1]相关,本数据文章包含有关在血管紧张素II(ANG II)诱导的心脏肥大中,MEL18介导的赖氨酸82位点HSF2去SUMO化的信息。与健康人心脏相比,分离的成人全心脏组织显示,在高血压患者心脏中,MEL18介导的HSF2-IGF-IIR途径上调。